ClinicalTrials.gov record
Completed Phase 4 Interventional

Investigation of a Novel Wound Gel to Improve Wound Healing in Chronic Wounds

ClinicalTrials.gov ID: NCT03686904

Public ClinicalTrials.gov record NCT03686904. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 12:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Investigating the Effect of an Anti-Biofilm Solution to Reduce Bacterial Burden and Accelerate Healing in Chronic Wounds.

Study identification

NCT ID
NCT03686904
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Georgetown University
Other
Enrollment
11 participants

Conditions and interventions

Interventions

  • Benzalkonium Gel Drug
  • Debridement Procedure
  • Saline Irrigation (SOC Irrigation) Other
  • benzalkonium irrigation Drug
  • standard of care topical gel Other

Drug · Procedure · Other

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 18, 2018
Primary completion
Feb 13, 2020
Completion
Feb 13, 2020
Last update posted
Jun 1, 2022

2018 – 2020

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Medstar Georgetown University Hospital Washington D.C. District of Columbia 20007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03686904, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2022 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03686904 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →